Institute of Genetics and Cancer
Institute of Genetics and Cancer

Innovation & impact

Translating our research to maximise impact on human health.

IGMM clinical impact

 In order to maximise the impact of our work on human health, the Institute of Genetics and Cancer aims, where appropriate, to:

  • Support wide dissemination of scientific discoveries through open access publishing and data sharing
  • Promote a culture of translation at the Institute supported by appropriate events and training
  • Collaborate with industrial and NHS partners
  • Identify, develop and, where appropriate, partner scientific discovery with potential for translation
  • License our intellectual property in an exclusive or non-exclusive manner
  • Form spin out companies

Enquiries about Institute of Genetics and Cancer translation, commercialisation and partnering opportunities:

Andrea Taylor, Business Development Manager, Edinburgh Innovations

Institute of Genetics and Cancer Translation and Commercialisation Board (TCB)

IGMM Translation and Commercialisation Board (TCB)
Driving translation of Institute of Genetics and Cancer science.

Our goals are to carry out excellent genetic, genomic, cellular and clinical science, so that we contribute significantly to the understanding of human development, physiology and disease, and apply this knowledge for the benefit of patients and society. This broad vision reflects the diversity of research within the Institute and we aspire to be world class in key themes, bringing innovation and unique twists to Institute of Genetics and Cancer discovery and translation.

Professor Margaret Frame FRSE FMedSciDirector, Institute of Genetics and Cancer at the University of Edinburgh